Planet Microcap Podcast | Microcap Investing Strategies

My guest on the show today is Francois Roberge, President and CEO of LSL Pharma Group (TSX-V: LSL). LSL Pharma Group is a Canadian integrated pharmaceutical company specializing in the development, manufacturing and distribution of high-quality natural health products and dietary supplements in solid dosage forms, as well as high quality sterile ophthalmic pharmaceutical products, according to the company's website. I invited on Francois to discuss: Developing their own pharmaceutical products in-house vs. partnering Why there is an opportunity to consolidate the fragmented CDMO (contract development and manufacturing organization) market for niche products LSL's natural health and Ophthalmic products; and, Francois' 3-5 year vision for the company For more information about LSL Pharma Group, please visit: https://www.groupelslpharma.com/ This podcast was recorded and is being made available by SNN, Inc. (together with its affiliates and its and their employees, “SNN”) solely for informational purposes. SNN